Confirme su ubicación

Confirme su ubicación o seleccione un país de la lista para ponerse en contacto con su mercado Ottobock local. Nos encargaremos de que, en el futuro, sea redirigido a la página que ha seleccionado para que se encuentre siempre en el lugar correcto.


Ottobock North America appoints medical device industry veteran Dr. Wilson Constantine as CEO & Regional President

December 28th, 2022

Ottobock, the global health-tech leader helping people gain freedom of movement, and its Board of Directors has appointed Dr. Wilson P. Constantine as the new CEO and President of its North America operations. Dr. Constantine, a medical device industry veteran with more than 25 years of leading companies to double-digit growth, will report to Oliver Jakobi, Global CEO/CSO of Ottobock SE & Co. KGaA. He succeeds Marc C. Lundeberg, who left the company in August to pursue other opportunities.

"Wilson’s experience leading North American operations and extensive expertise with medical technology will be of tremendous benefit to Ottobock as we enter the next phase of development and continue to build our presence across the U.S. and Canada, Jakobi said. “His proven track-record of leading meaningful change and growth in organizations will help Ottobock as we continue to innovate to help people regain their quality of life.”

Prior to joining Ottobock, Dr. Constantine was the President, of the Americas Region of Smiths Medical, a leading global medical device manufacturer. Dr. Constantine also served as President and Chief Executive Officer of Nihon Kohden America, where he led the company’s reorganization and transformed it into the fastest-growing company in the patient monitoring market.

Previously, Constantine was Chief Executive Officer of Private Equity held Monarch Medical Technologies, and served in executive leadership roles at Stryker Orthopaedics, Misonix Inc., Henry Schein Inc., Aesculap-B/Braun as well as other leading medical products suppliers, including units of and/or entities later acquired by Boston Scientific, Medtronic and Smith & Nephew.

“Ottobock has a tremendous history of developing industry-changing innovations that empower people and I am looking forward to the opportunity to continue to help those who need our advancements most,” Constantine said. “My goal is to continue to grow the company’s leadership and reinforce its position as a powerhouse in the prosthetics, orthotics and exoskeleton markets.”

Constantine holds a doctorate from Samuel Merritt University, completed the Executive Management Program at University of Notre Dame – Mendoza College of Business, and attended Loma Linda University for his undergraduate studies.

About Ottobock

For more than 100 years, Ottobock has been developing innovative fitting solutions for people with reduced mobility. As a Human Empowerment Company, Ottobock promotes freedom of movement, quality for life and independence. This is supported by more than 9,000 employees. With innovative power, outstanding technical solutions and services in the fields of Prosthetics, Orthotics, NeuroMobility and Patient Care, they enable people in 135 countries to live their lives the way they want them to. As the world market leader in wearable human bionics, the company founded in 1919 is constantly setting new standards and pushing ahead with the digitalisation of the industry – together with its partners, the medical supply companies and international research institutions. Since 2018, Ottobock has been transferring its expertise in biomechanics to exoskeletons for ergonomic workplaces. The international activities of the company are coordinated from the head office in Duderstadt (state of Lower Saxony). Ottobock has been supporting the Paralympic Games with its technical expertise since 1988.

Fotografía profesional del recién nombrado CEO de Ottobock, Dr. Wilson Constantine